Navigation Links
Cell Therapeutics, Inc. (CTI) to Present at 10th Annual BIO CEO & Investor Conference

SEATTLE, Feb. 6 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq: CTIC; MTAX) management will present at the 10th Annual BIO CEO & Investor Conference on Tuesday, February 12th at 1:15 PM in the West Foyer of the Waldorf-Astoria Hotel.

The presentation will also be webcast live with slides, and available for replay after the presentation. The webcast can be accessed at

BIO CEO & Investor Conference

CTI Presentation: Tuesday, February 12, 2008

1:15 PM EST/7:15 PM CET/10:15 AM PST

West Foyer, Waldorf-Astoria Hotel

Audio webcast with slides at

Media Contact: Investors Contact:

Cell Therapeutics, Inc. Cell Therapeutics, Inc.

Dan Eramian Leah Grant

T: 206.272.4343 T: 206.272.4345

F: 206.272.4434 F: 206.272.4434

Susan Callahan E:

T: 206.272.4472

F: 206.272.4434


SOURCE Cell Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Nile Therapeutics, Inc. to Present at Upcoming BIO CEO & Investor Conference
2. Velcura Therapeutics, Inc. Teams with International Discovery Sourcing Consultants to Develop New Therapeutic Molecules for Cancer and Bone Disease
3. Sonexa Therapeutics, Inc., Raises $30 Million in Series A Financing to Focus on Alzheimers Treatments
4. Cryo-Cell Announces Research Collaboration Agreement with Saneron CCEL Therapeutics, Inc.
5. Cell Therapeutics, Inc. (CTI) Shareholders Authorize Share Increase at Special Meeting of Shareholders
6. Velcura Therapeutics, Inc. Can Begin Clinical Trials Following Successful Investigational New Drug Application to U.S. FDA
7. Cell Therapeutics, Inc. (CTI) Prices $1.27 million (euros 856.000) Offering of Common Stock through Societe Generale
8. Cell Therapeutics, Inc. Announces Authorization to Publish Italian Listing Prospectus
9. Cell Therapeutics, Inc. (CTI) Hosts Conference Call to Discuss Update on Zevalin(R) Acquisition, CMS Reimbursement, and PIX301 Timeline
10. Pearl Therapeutics, Inc. Expands Its Senior Management Team With Top Talent in Clinical Development and Regulatory Affairs
11. Cell Therapeutics, Inc. (CTI) to Submit Marketing Authorization Application for XYOTAX(TM) for First-line Non-small Cell Lung Cancer Ahead of Schedule
Post Your Comments:
(Date:9/22/2014)... 22, 2014 This is a professional ... M-Phenylenediamine (mPDA) industry in Global and China. The ... definitions, applications and industry chain structure. Global market analysis ... focus on history, developments, trends and competitive landscape of ... situation is also offered. , The report also focuses ...
(Date:9/22/2014)... Research and Markets has announced ... Cellulose Industry Report 2014" report to their offering. ... Industry Report 2014 is a professional and in-depth study ... industry with a focus on the Chinese situation. ... industry including definitions, classifications, applications and industry chain structure. ...
(Date:9/22/2014)...  WIRB-Copernicus Group (WCG), the world,s largest provider ... research, announced today that its Western Institutional Review ... the Association for the Accreditation of Human Research ... for clinical research participants. WCG Chairman ... commented, "It is of utmost importance to WCG ...
(Date:9/21/2014)... Switzerland have succeeded in observing the "forbidden" infrared ... time. These extremely weak spectra offer perspectives for ... also contribute to the development of molecular clocks ... the scientific journal Nature Physics . , ... and light, is probably the most important method ...
Breaking Biology Technology:m-Phenylenediamine Industry: mPDA Global & China Trend Analysis Now Available at 2m-Phenylenediamine Industry: mPDA Global & China Trend Analysis Now Available at 3Global and Chinese Microcrystalline Cellulose Industry Report 2014 2Western IRB (WIRB) Awarded AAHRPP Reaccreditation 2Uncovering the forbidden side of molecules 2
... May 29 Sangamo BioSciences,Inc. (Nasdaq: SGMO ... CEO, will provide an update on Sangamo,s diabetic ... 6, 2008, at the Canaccord Adams,Diabetes and Obesity ... be webcast live and may be accessed via ...
... 29 Diplomat Specialty,Pharmacy, a leader in specialty ... (DTM) announced today that their specialty,pharmacy was one ... Roundtable,(NMCRT) held this month in Dallas, Texas. This ... managed care organizations together to,review and improve on ...
... NanoBio(R) Corporation, a,biopharmaceutical company focused on developing ... of infectious diseases, today,announced the appointment of David ... most recently served as President of Pharmaceutical Operations ... David to our Board of Directors and look,forward ...
Cached Biology Technology:Sangamo BioSciences to Present at the Canaccord Adams Diabetes and Obesity Conference 2Diplomat Specialty Pharmacy Sponsors National Managed Care Roundtable for Industry Executive Advisory Board 2David M. Stout Joins NanoBio Corporation's Board of Directors 2
(Date:9/21/2014)... autism are significantly less likely to report taking iron ... of children who are developing normally, a study by ... , Low iron intake was associated with a five-fold ... mother was 35 or older at the time of ... conditions such as obesity hypertension or diabetes. , The ...
(Date:9/21/2014)... MA -- In recent years, new strains of bacteria ... Each year, these superbugs, including drug-resistant forms of tuberculosis ... and kill at least 23,000. Despite the urgent need ... classes of antibiotics in the past decade. , MIT ... these superbugs. Using a gene-editing system that can disable ...
(Date:9/19/2014)... Jimmy Durante of dinosaurs a newly discovered ... new dinosaur, named Rhinorex condrupus by ... Young University, lived in what is now Utah ... Cretaceous period. , Rhinorex, which translates roughly into ... relative of other Cretaceous hadrosaurs like Parasaurolophus and ...
Breaking Biology News(10 mins):Mothers of children with autism less likely to have taken iron supplements 2Battling superbugs 2Battling superbugs 3Battling superbugs 4New hadrosaur noses into spotlight 2
... in New Guinea, one of which is the new smallest known ... issue of the online journal PLoS ONE , and the ... University. The new smallest vertebrate species is called Paedophryne ... it was found. The adult body size for these frogs ranges ...
... gene 15 (ISG15), a ubiquitin like protein, is highly ... How the elevated ISG15 pathway contributes to tumorigenic phenotypes ... published in the January 2012 issue of Experimental ... her co-investigators from the Louisiana State University School of ...
... humans arrive in Europe and Asia? At what rate have ... How did Neanderthal teeth and bones differ from ours? These ... Max Planck Weizmann Institute of Science Center in the ... the establishment of the Center is being signed today at ...
Cached Biology News:ISG15: A novel therapeutic target to slow breast cancer cell motility 2Weizmann Institute and Max Planck Society establish a joint center for archaeology and anthropology 2Weizmann Institute and Max Planck Society establish a joint center for archaeology and anthropology 3Weizmann Institute and Max Planck Society establish a joint center for archaeology and anthropology 4
Mouse monoclonal [SIT-01] to SIT ( Abpromise for all tested applications). entrezGeneID: 27240 SwissProtID: Q9Y3P8...
Anti-MMP-25 (Membrane-type MMP-6, Mt6MMP), hinge region; rabbit host...
Anti-MMP-25 (Membrane-type MMP-6, Mt6MMP), hinge region; rabbit host...
Anti-MMP-25 (Membrane-type MMP-6, Mt6MMP), hinge region; rabbit host...
Biology Products: